Breaking News Instant updates and real-time market news.

SCYX

Scynexis

$1.18

-0.01 (-0.84%)

09:29
10/15/18
10/15
09:29
10/15/18
09:29

Scynexis doses first patient in Phase 3 study of Ibrexafungerp

Scynexis announced the dosing of the first patient with a Candida auris infection, an emerging life-threatening and multidrug-resistant fungal pathogen, in a Phase 3 open-label study evaluating oral ibrexafungerp in patients with candidiasis caused by C. auris. Ibrexafungerp, the first representative of a novel oral and intravenous triterpenoid antifungal family, is in clinical development for the treatment of multiple serious fungal infections. The CARES study is a multi-center, open-label, single-arm study designed to evaluate the efficacy, safety and tolerability of oral ibrexafungerp in subjects with documented C. auris infections.

  • 27

    Nov

SCYX Scynexis
$1.18

-0.01 (-0.84%)

07/11/18
NEED
07/11/18
UPGRADE
Target $5
NEED
Buy
Scynexis upgraded to Buy at Needham after positive phase 2b data for SCY-078
As reported earlier, Needham analyst Alan Carr upgraded Scynexis (SCYX) to Buy from Hold with a price target of $5 after the company's positive Phase 2b trial results of oral SCY-078 in Vulvovaginal Candidiasis. The analyst notes that the data shows the 1-day 300mg BID SCY-078 is "at least equivalent and likely more effective" than the standard 150mg single dose of fluconazole made by Pfizer (PFE). Carr adds that the gastrointestinal tolerability of SCY-078 is also acceptable, which was a key concern in the earlier Phase 2a trial. The analyst further states that the new valuation accounts for expected commercialization of the drug in VVC amid a likely strong interest in a new oral agent suggested by his ObGyn survey last month.
07/11/18
NEED
07/11/18
UPGRADE
Target $5
NEED
Buy
Scynexis upgraded to Buy from Hold at Needham
Needham analyst Alan Carr upgraded Scynexis to Buy from Hold and set a $5 price target on the shares.
06/27/18
06/27/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zimmer Biomet (ZBH) initiated with an Underperform at Bernstein. 2. Abeona Therapeutics (ABEO) initiated with a Buy at B. Riley FBR. 3. Johnson & Johnson (JNJ) initiated with a Market Perform at Bernstein. 4. T-Mobile (TMUS) initiated with an Overweight at Barclays. 5. Scynexis (SCYX) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/27/18
MAXM
06/27/18
INITIATION
Target $6
MAXM
Buy
Scynexis initiated with a Buy at Maxim
Maxim analyst Jason McCarthy initiated Scynexis with a Buy rating and a price target of $6, saying the company's SCY-078 treatment is a "novel antifungal" with activity against both yeasts and molds that cause mucosal and/or invasive fungal infections. If approved, the analyst contends that the treatment can translate into high adoption as it has all the desirable treatment options - "safe, tolerable, broad spectrum, active against clinically relevant yeasts". McCarthy notes that the phase 2B trial for the drug in vulvovaginal candidiasis is ongoing, with findings expected in Q3 of this year.

TODAY'S FREE FLY STORIES

10:02
10/16/19
10/16
10:02
10/16/19
10:02
General news
Business Inventories data reported »

August Business…

10:02
10/16/19
10/16
10:02
10/16/19
10:02
General news
Housing Market Index data reported »

October Housing Market…

VRRM

Verra Mobility

$13.89

-0.14 (-1.00%)

10:01
10/16/19
10/16
10:01
10/16/19
10:01
Hot Stocks
Verra Mobility to acquire Pagatelia, terms not disclosed »

Verra Mobility announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

  • 13

    Nov

  • 14

    Nov

TIGR

UP Fintech

$3.90

-0.16 (-3.94%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Periodicals
UP Fintech accused by GeoInvesting of 'illegal money laundering scheme' »

GeoInvesting has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MERC

Mercer

$11.20

0.03 (0.27%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Conference/Events
Mercer participates in a conference call with JPMorgan »

LatAm Pulp & Paper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AYX

Alteryx

$104.75

-7.58 (-6.75%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Hot Stocks
Alteryx falls -6.8% »

Alteryx is down -6.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

CPS

Cooper-Standard

$33.60

-2.77 (-7.62%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Hot Stocks
Cooper-Standard falls -7.7% »

Cooper-Standard is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVD

American Vanguard

$13.50

-1.76 (-11.53%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Hot Stocks
American Vanguard falls -12.2% »

American Vanguard is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 19

    Nov

  • 20

    Nov

OMI

Owens & Minor

$6.85

0.42 (6.53%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Hot Stocks
Owens & Minor rises 6.2% »

Owens & Minor is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$7.41

0.45 (6.47%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Hot Stocks
Teva rises 6.3% »

Teva is up 6.3%, or 44c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MS

Morgan Stanley

$42.85

0.31 (0.73%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Options
Size opening call buy in Morgan Stanley ahead of earnings »

Size opening call buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 10

    Nov

  • 12

    Nov

DFIN

Donnelley Financial Solutions

$11.25

0.71 (6.74%)

10:00
10/16/19
10/16
10:00
10/16/19
10:00
Hot Stocks
Donnelley Financial Solutions rises 6.7% »

Donnelley Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCK

McKesson

$145.74

7.57 (5.48%)

, ABC

AmerisourceBergen

$86.20

3.02 (3.63%)

09:55
10/16/19
10/16
09:55
10/16/19
09:55
Options
Early notable gainers among liquid option names on October 16th »

Notable gainers among…

MCK

McKesson

$145.74

7.57 (5.48%)

ABC

AmerisourceBergen

$86.20

3.02 (3.63%)

CAH

Cardinal Health

$49.72

1.79 (3.73%)

DO

Diamond Offshore

$5.62

0.13 (2.37%)

EQT

EQT Corporation

$9.89

0.25 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 23

    Oct

  • 28

    Oct

  • 30

    Oct

  • 31

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

GOOG

Alphabet

$1,247.70

4.17 (0.34%)

09:55
10/16/19
10/16
09:55
10/16/19
09:55
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Subcommittee on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 18

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

09:55
10/16/19
10/16
09:55
10/16/19
09:55
Conference/Events
House Transportation & Intrastructure Committee to hold a hearing »

The Subcommittee on…

09:55
10/16/19
10/16
09:55
10/16/19
09:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

09:55
10/16/19
10/16
09:55
10/16/19
09:55
Conference/Events
The U.S. Commodity Futures Trading Commission to hold a meeting »

The CFTC discusses the…

HTHT

Huazhu Group

$33.91

-0.15 (-0.44%)

09:54
10/16/19
10/16
09:54
10/16/19
09:54
Downgrade
Huazhu Group rating change  »

Huazhu Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLS

Flowserve

$45.77

-0.07 (-0.15%)

09:52
10/16/19
10/16
09:52
10/16/19
09:52
Periodicals
Flowserve seen as potential activist target by Dealreporter »

Dealreporter, according…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

09:50
10/16/19
10/16
09:50
10/16/19
09:50
General news
U.S. business inventories preview: »

U.S. business inventories…

ABT

Abbott

$80.99

-1.07 (-1.30%)

09:49
10/16/19
10/16
09:49
10/16/19
09:49
Hot Stocks
Abbott says focused on organic execution »

Says: Continuing to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

MCK

McKesson

$144.00

5.83 (4.22%)

09:47
10/16/19
10/16
09:47
10/16/19
09:47
Hot Stocks
McKesson rises 4.1% »

McKesson is up 4.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 30

    Oct

DFIN

Donnelley Financial Solutions

$11.05

0.51 (4.84%)

09:47
10/16/19
10/16
09:47
10/16/19
09:47
Hot Stocks
Donnelley Financial Solutions rises 5.1% »

Donnelley Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USB

U.S. Bancorp

$54.43

0.7 (1.30%)

09:47
10/16/19
10/16
09:47
10/16/19
09:47
Hot Stocks
Breaking Hot Stocks news story on U.S. Bancorp »

U.S. Bancorp sees 2020 as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 12

    Nov

MFGP

Micro Focus

$14.53

0.64 (4.61%)

09:47
10/16/19
10/16
09:47
10/16/19
09:47
Hot Stocks
Micro Focus rises 5.1% »

Micro Focus is up 5.1%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.